美国药品 NDC（最近上市）
最近上市
| 商品名 | 药品通用名 | NDC代码 | 标签持有者 | 剂型 | 给药途径 | 活性成分 | 上市日期 | 注册申请号 |
|---|---|---|---|---|---|---|---|---|
| Midodrine Hydrochloride | Midodrine Hydrochloride | 0904-7640 | Major Pharmaceuticals | TABLET | ORAL | MIDODRINE HYDROCHLORIDE | 2026-09-01 | ANDA217271 |
| Midodrine Hydrochloride | Midodrine Hydrochloride | 0904-7641 | Major Pharmaceuticals | TABLET | ORAL | MIDODRINE HYDROCHLORIDE | 2026-09-01 | ANDA217271 |
| Midodrine Hydrochloride | Midodrine Hydrochloride | 0904-7641 | Major Pharmaceuticals | TABLET | ORAL | MIDODRINE HYDROCHLORIDE | 2026-09-01 | ANDA217271 |
| Midodrine Hydrochloride | Midodrine Hydrochloride | 0904-7642 | Major Pharmaceuticals | TABLET | ORAL | MIDODRINE HYDROCHLORIDE | 2026-09-01 | ANDA217271 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | 10135-823 | Marlex Pharmaceuticals, Inc. | TABLET, EXTENDED RELEASE | ORAL | METFORMIN HYDROCHLORIDE | 2026-09-01 | ANDA202306 |